Immunotherapy is an effective treatment option for gynecological malignancies. Radiologists dealing with gynecological patients undergoing treatment with immune checkpoint inhibitors should be aware of unconventional immune-related imaging features for the evaluation of tumor response and immune-related adverse events. In this paper, immune checkpoint inhibitors used for gynecological malignancies and their mechanisms of action are briefly presented. In the second part, patterns of pseudoprogression are illustrated, and different forms of immune-related adverse events are discussed.

Russo, L., Avesani, G., Gui, B., Trombadori, C. M. L., Salutari, V., Perri, M. T., Di Paola, V., Rodolfino, E., Scambia, G., Manfredi, R., Immunotherapy-related imaging findings in patients with gynecological malignancies: What radiologists need to know, <<KOREAN JOURNAL OF RADIOLOGY>>, 2021; 22 (8): 1310-1322. [doi:10.3348/kjr.2020.1299] [http://hdl.handle.net/10807/205798]

Immunotherapy-related imaging findings in patients with gynecological malignancies: What radiologists need to know

Russo L.;Avesani G.;Gui B.;Trombadori C. M. L.;Salutari V.;Perri M. T.;Di Paola V.;Rodolfino E.;Scambia G.;Manfredi R.
2021

Abstract

Immunotherapy is an effective treatment option for gynecological malignancies. Radiologists dealing with gynecological patients undergoing treatment with immune checkpoint inhibitors should be aware of unconventional immune-related imaging features for the evaluation of tumor response and immune-related adverse events. In this paper, immune checkpoint inhibitors used for gynecological malignancies and their mechanisms of action are briefly presented. In the second part, patterns of pseudoprogression are illustrated, and different forms of immune-related adverse events are discussed.
eng
Russo, L., Avesani, G., Gui, B., Trombadori, C. M. L., Salutari, V., Perri, M. T., Di Paola, V., Rodolfino, E., Scambia, G., Manfredi, R., Immunotherapy-related imaging findings in patients with gynecological malignancies: What radiologists need to know, <>, 2021; 22 (8): 1310-1322. [doi:10.3348/kjr.2020.1299] [http://hdl.handle.net/10807/205798]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10807/205798
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact